差價合約是複雜的工具,並且由於槓桿作用而具有快速虧損的高風險。 84% 的散戶投資者賬戶在與該提供商交易差價合約時虧損您應該考慮自己是否了解差價合約的運作方式,以及您是否有能力承擔損失資金的高風險。

交易 Caribou Biosciences, Inc. - CRBU CFD

5.11
0.39%
0.05
低: 4.93
高: 5.24
Market Trading Hours* (UTC) Opens on Friday at 13:30

Mon - Fri: 13:30 - 20:00

  • 概括
  • 曆史數據
  • 活動
  • 收入報表
  • 資産負債表
  • 現金流
  • 所有權
交易條件
價差 0.05
多頭倉位隔夜費用

Long position overnight fee


Margin. Your investment $1,000.00
隔夜費用 -0.024874 %
Charges from borrowed part ($-0.99)
Trade size with leverage ~ $5,000.00
來自槓桿的資金 ~ $4,000.00

前往平台
-0.024874%
空頭倉位隔夜費用

Short position overnight fee


Margin. Your investment $1,000.00
隔夜費用 0.002651 %
Charges from borrowed part ($0.11)
Trade size with leverage ~ $5,000.00
來自槓桿的資金 ~ $4,000.00

前往平台
0.002651%
隔夜費時間 21:00 (UTC)
最小成交量 1
貨幣 USD
保證金 20%
股票交易 United States of America
交易委員會 0%

*Information provided by Capital.com

關鍵數據
前收盤價* 5.13
開盤價* 5.24
1 年變化* -44.26%
日範圍* 4.93 - 5.24
52 周範圍 4.12-13.19
平均交易量(10 天) 584.26K
平均交易量(3 個月) 10.05M
市值 316.92M
市盈率 -100.00K
流通股 61.30M
收入 13.85M
EPS -1.63
股息(收益率 %) N/A
貝塔 -100.00K
下一個財報發布日期 N/A

所有數據都是由Refinitiv提供的, 除了標有星號的數據, 這是*由 Capital.com 提供的數據

  • 上週
  • 上個月
  • 去年
  • 過去兩年
  • 最大
  • 每日
  • 每週
  • 每月
日期 關閉 更改 變化 (%) 打開
Mar 30, 2023 5.11 -0.04 -0.78% 5.15 5.25 4.90
Mar 29, 2023 5.13 0.34 7.10% 4.79 5.18 4.67
Mar 28, 2023 4.69 0.03 0.64% 4.66 4.87 4.54
Mar 27, 2023 4.68 0.06 1.30% 4.62 4.78 4.49
Mar 24, 2023 4.62 0.38 8.96% 4.24 4.69 4.18
Mar 23, 2023 4.26 -0.11 -2.52% 4.37 4.43 4.10
Mar 22, 2023 4.32 -0.43 -9.05% 4.75 4.75 4.31
Mar 21, 2023 4.79 -0.08 -1.64% 4.87 4.90 4.74
Mar 20, 2023 4.85 -0.04 -0.82% 4.89 4.91 4.69
Mar 17, 2023 4.91 -0.02 -0.41% 4.93 5.02 4.80
Mar 16, 2023 5.02 -0.07 -1.38% 5.09 5.15 4.91
Mar 15, 2023 5.15 0.10 1.98% 5.05 5.25 5.02
Mar 14, 2023 5.18 -0.25 -4.60% 5.43 5.51 5.10
Mar 13, 2023 5.30 0.25 4.95% 5.05 5.34 5.02
Mar 10, 2023 5.14 -0.29 -5.34% 5.43 5.48 4.93
Mar 9, 2023 5.48 -0.35 -6.00% 5.83 5.85 5.33
Mar 8, 2023 5.85 0.02 0.34% 5.83 5.92 5.75
Mar 7, 2023 5.86 0.03 0.51% 5.83 6.04 5.70
Mar 6, 2023 5.77 -0.32 -5.25% 6.09 6.09 5.54
Mar 3, 2023 6.09 0.17 2.87% 5.92 6.11 5.86

Caribou Biosciences, Inc. Events

时间(协调世界时) (UTC) 国家 事件
No events scheduled
查看所有活动
  • 年度
  • 每季度
2022 2021 2020 2019
總收入 13.851 9.598 12.361 5.788
收入 13.851 9.598 12.361 5.788
總營業費用 120.25 74.993 48.485 40.093
銷售/一般/行政費用,總計 38.02 24.322 14.06 16.458
研究與開發 82.23 52.255 34.425 23.635
營業收入 -106.399 -65.395 -36.124 -34.305
利息收入(費用),非經營淨值 -0.133 0.14 -0.517 3.337
其他,淨值 7.181 -1.347 0.514 0
稅前淨收入 -99.351 -66.602 -36.127 -30.968
稅後淨收入 -99.421 -66.923 -34.308 -23.431
未計算非常項目前的淨收益 -99.421 -66.923 -34.308 -23.431
淨收入 -99.421 -66.923 -34.308 -23.431
普通股股東可獲收益 (不含非經常性項目) -99.421 -66.923 -34.308 -23.431
普通股股東可獲收益 (含非經常性項目) -99.421 -66.923 -34.308 -23.431
攤薄淨收入 -99.421 -66.923 -34.308 -23.431
攤薄後加權平均股 60.8011 60.2632 56.7092 56.7092
扣除特別項目的每股攤薄盈利 -1.63518 -1.11051 -0.60498 -0.41318
Dividends per Share - Common Stock Primary Issue 0 0 0
每股正常攤薄盈利 -1.63518 -1.1276 -0.60498 -0.41318
異常費用(收入) 0 -1.584
Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
總收入 3.692 3.303 4.192 2.664 2.559
收入 3.692 3.303 4.192 2.664 2.559
總營業費用 34.27 29.84 32.623 23.517 22.964
銷售/一般/行政費用,總計 8.534 9.849 10.044 9.593 7.853
研究與開發 25.736 19.991 22.579 13.924 15.111
營業收入 -30.578 -26.537 -28.431 -20.853 -20.405
利息收入(費用),非經營淨值 -0.06 0.031 -0.016 0.163 0.076
其他,淨值 3.719 -0.141 1.75 1.602 2.171
稅前淨收入 -26.919 -26.647 -26.697 -19.088 -18.158
稅後淨收入 -26.989 -26.647 -26.697 -19.088 -18.479
未計算非常項目前的淨收益 -26.989 -26.647 -26.697 -19.088 -18.479
淨收入 -26.989 -26.647 -26.697 -19.088 -18.479
普通股股東可獲收益 (不含非經常性項目) -26.989 -26.647 -26.697 -19.088 -18.479
普通股股東可獲收益 (含非經常性項目) -26.989 -26.647 -26.697 -19.088 -18.479
攤薄淨收入 -26.989 -26.647 -26.697 -19.088 -18.479
攤薄後加權平均股 61.01 60.8869 60.7577 60.5462 60.2632
扣除特別項目的每股攤薄盈利 -0.44237 -0.43765 -0.4394 -0.31526 -0.30664
Dividends per Share - Common Stock Primary Issue 0 0 0 0
每股正常攤薄盈利 -0.44237 -0.43765 -0.4394 -0.31526 -0.30664
異常費用(收入) 0 0 0 0
  • 年度
  • 每季度
2021 2020 2019
流動資産總額 391.192 24.306 57.008
現金和短期投資 375.832 15.953 49.471
現金等價物 240.42 15.953 41.07
短期投資 135.412 0 8.401
應收賬款總額,淨額 8.124 5.16 3.982
Accounts Receivable - Trade, Net 2.641 1.478 0.841
Prepaid Expenses 6.565 2.433 3.182
Other Current Assets, Total 0.671 0.76 0.373
Total Assets 442.356 36.046 61.933
Property/Plant/Equipment, Total - Net 4.887 3.502 4.332
Property/Plant/Equipment, Total - Gross 8.964 6.598 6.59
Accumulated Depreciation, Total -4.077 -3.096 -2.258
Long Term Investments 45.302 7.626 0
Other Long Term Assets, Total 0.975 0.612 0.593
Total Current Liabilities 25.829 12.389 10.078
Accounts Payable 3.99 2.601 2.537
Accrued Expenses 12.089 8.151 5.653
Notes Payable/Short Term Debt 0 0 0
Current Port. of LT Debt/Capital Leases 0 0.654 0
Other Current Liabilities, Total 9.75 0.983 1.888
Total Liabilities 54.531 18.16 13.147
Total Long Term Debt 0 0.924 0
Long Term Debt 0 0.924 0
Deferred Income Tax 0.476 0.155 0.65
Other Liabilities, Total 28.226 4.692 2.419
Total Equity 387.825 17.886 48.786
Preferred Stock - Non Redeemable, Net 0 41.323 41.323
Common Stock 0.006 0.001 0.001
Additional Paid-In Capital 485.748 7.433 4.025
Retained Earnings (Accumulated Deficit) -97.794 -30.871 3.437
Total Liabilities & Shareholders’ Equity 442.356 36.046 61.933
Total Common Shares Outstanding 60.2632 56.7092 56.7092
Other Equity, Total -0.135
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
流動資産總額 368.01 391.192 449.047 142.967 155.925
現金和短期投資 353.731 375.832 435.31 129.524 145.924
現金等價物 147.63 240.42 435.31 129.524 145.924
應收賬款總額,淨額 6.037 8.124 7.785 8.407 5.825
Accounts Receivable - Trade, Net 1.868 2.641 2.431 0.832 1.049
Prepaid Expenses 7.276 6.565 5.189 3.759 3.096
Other Current Assets, Total 0.966 0.671 0.763 1.277 1.08
Total Assets 445.997 442.356 461.96 158.397 167.965
Property/Plant/Equipment, Total - Net 31.765 4.887 4.477 4.408 3.38
Property/Plant/Equipment, Total - Gross 36.15 8.964 8.282 7.952 6.695
Accumulated Depreciation, Total -4.385 -4.077 -3.805 -3.544 -3.315
Long Term Investments 44.758 45.302 7.626 7.626 7.626
Other Long Term Assets, Total 1.464 0.975 0.81 3.396 1.034
Total Current Liabilities 26.667 25.829 26.158 26.007 22.21
Accounts Payable 1.814 3.99 3.482 4.029 3.117
Accrued Expenses 11.215 12.089 12.288 11.034 10.929
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0 0 0 0.655
Other Current Liabilities, Total 13.638 9.75 10.388 10.944 7.509
Total Liabilities 74.2 54.531 57.559 55.938 53.504
Total Long Term Debt 0 0 0 0 0.926
Long Term Debt 0 0 0 0.926
Deferred Income Tax 0.476 0.476 0.155 0.155 0.155
Other Liabilities, Total 47.057 28.226 31.246 29.776 30.213
Total Equity 371.797 387.825 404.401 102.459 114.461
Preferred Stock - Non Redeemable, Net 0 0 0 150.15 150.15
Common Stock 0.006 0.006 0.006 0.001 0.001
Additional Paid-In Capital 489.762 485.748 483.71 10.649 8.34
Retained Earnings (Accumulated Deficit) -116.882 -97.794 -79.315 -58.341 -44.03
Total Liabilities & Shareholders’ Equity 445.997 442.356 461.96 158.397 167.965
Total Common Shares Outstanding 60.6896 60.2632 60.0213 59.9708 56.7092
短期投資 206.101 135.412
Other Equity, Total -1.089 -0.135
  • 年度
  • 每季度
2021 2020 2019
淨收入/起跑線 -66.923 -34.308 -23.431
經營活動産生的現金 -32.519 -33.215 -32.006
經營活動産生的現金 0.984 0.9 0.751
非現金物品 4.353 0.016 -1.059
Cash Taxes Paid 0.011 0.021 1.809
營運資金的變化 29.067 0.177 -8.267
投資活動産生的現金 -176.397 6.363 27.233
資本支出 -2.121 -0.317 -0.884
其他投資現金流量項目,總計 -174.276 6.68 28.117
融資活動産生的現金 433.429 1.735 0.172
股票的發行(報廢),淨額 432.398 1.848 0.217
債務的發行(退還),淨額 1.031 -0.113 -0.045
現金淨變化 224.513 -25.117 -4.601
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -19.088 -66.923 -48.444 -27.47 -13.159
Cash From Operating Activities -21.673 -32.519 -11.13 3.837 20.313
Cash From Operating Activities 0.308 0.984 0.711 0.451 0.221
Non-Cash Items 2.215 4.353 4.88 1.542 1.036
Cash Taxes Paid 0 0.011 0.011 0.011 0
Cash Interest Paid 0 0.001
Changes in Working Capital -5.108 29.067 31.723 29.314 32.215
Cash From Investing Activities -72.107 -176.397 -2.436 -0.506 -0.022
Capital Expenditures -0.723 -2.121 -1.436 -0.506 -0.022
Other Investing Cash Flow Items, Total -71.384 -174.276 -1 0 0
Cash From Financing Activities 0.99 433.429 432.969 110.286 109.68
Issuance (Retirement) of Stock, Net 0.99 432.398 431.938 109.957 109.799
Issuance (Retirement) of Debt, Net 0 1.031 1.031 1.031 -0.119
Net Change in Cash -92.79 224.513 419.403 113.617 129.971
Financing Cash Flow Items -0.702
投資者名稱 投資者類型 流通股百分比 持有股份 股份變動 持有日期 換手率
PFM Health Sciences, LP Hedge Fund 7.2754 4459783 -1540217 2022-12-31 MED
BlackRock Institutional Trust Company, N.A. Investment Advisor 6.6832 4096777 277588 2022-12-31 LOW
Haurwitz (Rachel E. Ph.D.) Individual Investor 5.5129 3379395 10000 2023-03-20 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 5.2184 3198893 803423 2022-12-31 LOW
Avidity Partners Management LP Hedge Fund 4.7025 2882600 -290000 2022-12-31 HIGH
Rokos Capital Management LLP Hedge Fund 4.4831 2748139 840630 2022-12-31 HIGH
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 4.1939 2570827 26789 2022-12-31 LOW
Pictet Asset Management Ltd. Investment Advisor/Hedge Fund 4.1662 2553878 -737020 2022-12-31 LOW
Elmwood Wealth Management, INC. Investment Advisor 3.8569 2364240 0 2022-12-31 LOW
EIDP Inc Corporation 3.3573 2058000 -1093311 2022-05-31 MED
BofA Global Research (US) Research Firm 3.008 1843902 1668395 2022-12-31 LOW
Fidelity Management & Research Company LLC Investment Advisor 2.3541 1443046 -547 2022-12-31 LOW
Morgan Stanley & Co. LLC Research Firm 1.982 1214933 30615 2022-12-31 MED
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.6819 1030987 45617 2022-12-31 LOW
Alkeon Capital Management LLC Investment Advisor/Hedge Fund 1.4575 893424 -138016 2022-12-31 LOW
Fidelity International Investment Advisor 1.404 860666 0 2022-12-31 LOW
Assenagon Asset Management S.A. Investment Advisor 1.3944 854738 55247 2022-12-31 HIGH
Maverick Capital, Ltd. Hedge Fund 1.0645 652542 0 2022-12-31 MED
Tekla Capital Management LLC Investment Advisor 0.9252 567147 0 2022-12-31 LOW
JPMorgan Asset Management U.K. Limited Investment Advisor/Hedge Fund 0.9215 564855 -1059 2022-12-31 LOW

為什麼選擇Capital.com?我們用表現來證明自己。

Capital.com Group

500K+

貿易商

92K+

每月活躍客戶

$53M+

每月投資額

$30M+

每月提取

差價合約交易計算器

如果您在特定日期(選取一個日期)開立差價合約交易並在不同日期(選取一個日期)關閉交易,計算您的假設盈虧。

交易佣金
0
  • 1:1
槓桿
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投資
交易規模(槓桿 x 投資):
打開

關閉

做空 做多
Industry: Biotechnology & Medical Research (NEC)

2929 7Th Street, Ste 120
BERKELEY
CALIFORNIA 94710
US

收入報表

  • Annual
  • Quarterly

人們也觀看

BTC/USD

28,000.60 Price
-0.680% 1D Chg, %
多頭倉位隔夜費用 -0.0616%
空頭倉位隔夜費用 0.0137%
隔夜費時間 21:00 (UTC)
價差 60.00

US100

12,962.10 Price
+0.000% 1D Chg, %
多頭倉位隔夜費用 -0.0249%
空頭倉位隔夜費用 0.0027%
隔夜費時間 21:00 (UTC)
價差 1.8

Gold

1,980.21 Price
+0.060% 1D Chg, %
多頭倉位隔夜費用 -0.0180%
空頭倉位隔夜費用 0.0098%
隔夜費時間 21:00 (UTC)
價差 0.30

Oil - Crude

75.03 Price
+0.550% 1D Chg, %
多頭倉位隔夜費用 -0.0170%
空頭倉位隔夜費用 -0.0049%
隔夜費時間 21:00 (UTC)
價差 0.03

還在尋找值得信賴的經紀商?

加入全球 500.000 多名交易者,選擇與 Capital.com 交易

1. 建立並驗證您的賬戶 2. 存入您的第一筆資金 3. 您已準備就緒。開始交易